IVERIC bio
ISEE
ISEE was delisted on the 10th of July, 2023.
128 hedge funds and large institutions have $537M invested in IVERIC bio in 2021 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 39 increasing their positions, 39 reducing their positions, and 12 closing their positions.
207% more call options, than puts
Call options by funds: $2.26M | Put options by funds: $737K
108% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 12
83% more capital inflows, than outflows
Capital inflows: $69.3M | Capital outflows: $37.9M
11% more funds holding
Funds holding: 115 → 128 (+13)
5.25% more ownership
Funds ownership: 88.98% → 94.23% (+5.2%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 39
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Yiheng Capital Management
San Francisco,
California
|
+$14.7M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$11.5M |
| 3 |
Avidity Partners Management
Dallas,
Texas
|
+$9.03M |
| 4 |
Logos Global Management
San Francisco,
California
|
+$8.39M |
| 5 |
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$4.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Avoro Capital Advisors
New York
|
-$5.32M |
| 2 |
Soleus Capital Management
Greenwich,
Connecticut
|
-$3.69M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.23M |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.16M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
-$2.79M |
ISEE Hedge Fund Activity: Q2 2021 in Review
128 of the 5,770 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio (ISEE) for Q2 2021, worth a combined $537M — up 8.4% from $496M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new ISEE positions and 12 closed out — a net gain of 13 holders — while 39 added to existing stakes and 39 trimmed.
The largest buyer was Yiheng Capital Management, adding an estimated $14.7M. The largest seller was Avoro Capital Advisors, cutting an estimated $5.32M.
- 128 institutional investors held IVERIC bio (ISEE) as of Q2 2021, up from 115 in Q1 2021.
- Funds reported $537M of IVERIC bio stock for Q2 2021, up 8.4% quarter-over-quarter.
- 25 funds opened new IVERIC bio positions in Q2 2021 and 12 closed out, a net change of +13 holders.
- The largest IVERIC bio buyer in Q2 2021 was Yiheng Capital Management, an estimated $14.7M added.
- The largest IVERIC bio seller in Q2 2021 was Avoro Capital Advisors, an estimated $5.32M sold.
Based on aggregated 13F filings for Q2 2021.